O'Gorman Cedric 4
4 · RELMADA THERAPEUTICS, INC. · Filed Jan 13, 2023
Insider Transaction Report
Form 4
O'Gorman Cedric
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-06−400,000→ 400,000 totalExercise: $3.29Exp: 2033-01-06→ Common stock (400,000 underlying)
Footnotes (1)
- [F1]The shares vest in 16 equal quarterly installments commencing on April 6, 2023.